News Announcement

Aspira Pathlab & Diagnostics: Announcement under Regulation 30 (LODR)-Change in Management

Pursuant to Regulation 30 of the Listing (Obligations & Disclosure Requirements) Regulations 2015 this is to inform that the Board of Directors in its meeting held on June 13 2020 (on the recommendation of the Nomination and Remuneration Committee) approved the re-designation of Dr. Pankaj Shah from Managing Director to Managing Director(MD) and Chief Executive officer(CEO) of the Company.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.